首页> 外文期刊>The Internet Journal of Microbiology >Enterococci: Emerging Drug Resistant Bacteria In Hospital Acquired Infections At Hospital Kuala Lumpur, Malaysia
【24h】

Enterococci: Emerging Drug Resistant Bacteria In Hospital Acquired Infections At Hospital Kuala Lumpur, Malaysia

机译:肠球菌:马来西亚吉隆坡医院的医院获得性感染中的新兴耐药细菌

获取原文
获取外文期刊封面目录资料

摘要

Enterococci are the most common pathogens in hospital acquired infections. Some of them are resistant to Vancomycin(VRE) and some are susceptible to Vancomycin (VSE). The present study was carried out to identify enterococci from clinical cases and to illustrate their clinical features and drug resistance characteristics. Antibiotics susceptibility of the identified bacteria was determined by disk diffusion method and E-test. Drug resistance properties were evaluated against ampicillin, gentamicin, vancomycin, teicoplanin and linezolid. Relating to clinical features, 244 cases of enterococci infected patients were identified at hospital Kuala Lumpur (HKL) Malaysia based on clinical information from the hospital. Of the patients 21% had history of urinary tract infections, 17.2% end stage renal disease, 12.2% sepsis, 8.4% malignancy, 12.2% had head injury and neurological problems, 4.2% diabetes mellitus and other clinical manifestations .In case of Vancomycin resistant enterococci infection, the clinical features of the patients were: end stage renal failure 3/6 (50%) and others with diabetes mellitus, interstitial lung disease and nephrotic syndrome. The patients of the enterococci infections were more prevalent in nephrology-urology unit (39%) and medical wards (including ICU, 23%) The findings would serve as an alert to the clinicians of the emergence of infections by enterococci and encourage implementation of appropriate infection control measures in order to curb further rise in prevalence. Introduction Enterococci normally present in the human intestines and in the female genital tract and are often found in the environment. Recent National Nosocomial Infections Surveillance1 reveals that these enterococci remain in the top 3 most common pathogens that cause nosocomial infections. These are: urinary tract infections, bloodstream infections, and wound infections in hospitalized patients. Enterococci infections typically occur in very ill debilitated patients who have been exposed to broad-spectrum antibiotics. According to NNIS2 data from January 2003 through December 2003, more than 28% of enterococci isolates were found to be associated infections in incentive care unit (ICU) of 300 participating hospitals.The acquisition of vancomycin resistance by enterococci has seriously affects treatment and infection control program which leaves clinicians treating VRE infections with limited therapeutic options (Fraser, 2010)NNIS2 reported that more than 25% of health care-associated enterococcal infections were associated with organisms resistant to vancomycin. In Malaysia 2006, a confirmed case of vancomycin resistant Enterococci isolated from blood culture of a young woman with chronic renal failure was first reported in Hospital Kuala Lumpur (HKL).3 However, later on, no systematic study was undertaken to determine the prevalence of enterococci infections from the hospitalized patients in Malaysia. Therefore, the present study was undertaken to determine the prevalence of enterococci infections in hospitalized patients and determination of their clinical features and drug resistance nature. Materials and Methods Study areaThe study was carried out during May 2007 to April 2008 at Hospital Kuala Lumpur (HKL), Malaysia. The hospital consists of 3000 beds and 90 wards and provides services and acts as a reference centre for the hospitals of other states, in Malaysia. Study population and sample collectionA total number of 244 samples obtained from the patients of different infections during the period. The samples included blood, urine, pus, tissue, body fluids and swabs from wound and placenta. The samples were sent to the Microbiology Laboratory, Department of Medical Microbiology and Immunology, Faculty of Medicine, University Kebangsaan Malaysia for identification and characterization.Information on clinical dataInformation on patient’s profiles :age, diagnosis, risk factors such as duration of hospitalization (prolonged >2
机译:肠球菌是医院获得性感染中最常见的病原体。其中一些对万古霉素(VRE)有抗性,而另一些对万古霉素(VSE)易感。进行本研究以从临床病例中鉴定肠球菌并说明其临床特征和耐药性特征。通过圆盘扩散法和E-test测定所鉴定细菌的抗生素敏感性。评估了针对氨苄青霉素,庆大霉素,万古霉素,替考拉宁和利奈唑胺的耐药性。关于临床特征,根据医院的临床信息在马来西亚吉隆坡(HKL)医院鉴定出244例肠球菌感染患者。其中21%有泌尿系统感染史,17.2%终末期肾病,12.2%败血症,8.4%恶性,12.2%有头部受伤和神经系统疾病,4.2%糖尿病和其他临床表现。万古霉素耐药肠球菌感染,患者的临床特征为:晚期肾衰竭3/6(50%),其他伴有糖尿病,间质性肺病和肾病综合征。肠球菌感染的患者在肾病-泌尿科和内科病房(包括ICU,占23%)中更为普遍,这一发现将提醒临床医生肠球菌感染的发生,并鼓励采取适当的措施。为了控制感染率的进一步上升,采取了感染控制措施。简介肠球菌通常存在于人的肠道和女性生殖道中,并且经常在环境中发现。最近的国家医院感染监测1显示,这些肠球菌仍是引起医院感染的三大最常见病原体。这些是:住院患者的尿路感染,血液感染和伤口感染。肠球菌感染通常发生在已暴露于广谱抗生素的严重虚弱的患者中。根据NNIS2的2003年1月至2003年12月的数据,在300所参与医院的激励性护理部门(ICU)中发现超过28%的肠球菌分离株与感染相关。肠球菌对万古霉素的耐药性严重影响了治疗和感染控制该计划使临床医生只能以有限的治疗选择来治疗VRE感染(Fraser,2010年)。NNIS2报告说,超过25%的医疗保健相关肠球菌感染与耐万古霉素的生物有关。在马来西亚,2006年,吉隆坡(HKL)医院首次报道了一名确诊的万古霉素耐药肠球菌病例,该病例是从一名患有慢性肾功能衰竭的年轻妇女的血液培养物中分离出来的。3但是,此后,没有进行系统的研究来确定该病的患病率。来自马来西亚住院患者的肠球菌感染。因此,本研究旨在确定住院患者肠球菌感染的患病率,并确定其临床特征和耐药性。材料和方法研究区域该研究于2007年5月至2008年4月在马来西亚吉隆坡(HKL)医院进行。该医院由3000张病床和90个病房组成,提供服务,并作为马来西亚其他州医院的参考中心。研究人群和样本收集在此期间从不同感染患者中获得的244个样本总数。样本包括伤口,胎盘的血液,尿液,脓液,组织,体液和拭子。样品被送至马来西亚Kebangsaan大学医学院医学微生物学和免疫学系的微生物学实验室进行鉴定和表征。临床数据信息患者资料的信息:年龄,诊断,住院时间等危险因素(延长> 2

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号